News · 18 November 2026

Isomorphic Labs raises $5bn to put AI-designed drugs into trials

18 November 2026 · Business · Tech_Ai

Isomorphic Labs raises $5bn to put AI-designed drugs into trials
Picture: BioPharma Dive · BioPharma Dive lead image · unknown

The round was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining and Alphabet taking part. Isomorphic was spun out of DeepMind in 2021 and is run by Demis Hassabis. It raised $2.1 billion in May. The company reports positive preclinical results in oncology and immunology, and has no approved drug yet.

Where this came from. 4 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026